{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:15:17Z","timestamp":1777875317618,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.7759\/cureus.108049","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:32:59Z","timestamp":1777584779000},"source":"Crossref","is-referenced-by-count":0,"title":["An Interesting Case of Sulphonylurea-Responsive Permanent Neonatal Diabetes Mellitus With Potassium Channel Mutation"],"prefix":"10.7759","author":[{"given":"Kristina","family":"O'Connell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Nadernejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb","family":"Bupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Dewoolkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2017.10.006","article-title":"Neonatal diabetes mellitus: an update on diagnosis and management","volume":"45","author":"Lemelman MB","year":"2018","unstructured":"Lemelman MB, Letourneau L, Greeley SA. Neonatal diabetes mellitus: an update on diagnosis and management. Clin Perinatol. 2018, 45:41-59. 10.1016\/j.clp.2017.10.006","journal-title":"Clin Perinatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1145","article-title":"Diabetes presentation in infancy: high risk of diabetic ketoacidosis","volume":"40","author":"Letourneau LR","year":"2017","unstructured":"Letourneau LR, Carmody D, Wroblewski K, et al.. Diabetes presentation in infancy: high risk of diabetic ketoacidosis. Diabetes Care. 2017, 40:e147-8. 10.2337\/dc17-1145","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2010.03.004","article-title":"Neonatal diabetes mellitus: a model for personalized medicine","volume":"21","author":"Greeley SA","year":"2010","unstructured":"Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson LH. Neonatal diabetes mellitus: a model for personalized medicine. Trends Endocrinol Metab. 2010, 21:464-72. 10.1016\/j.tem.2010.03.004","journal-title":"Trends Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20124","article-title":"KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes","volume":"25","author":"Massa O","year":"2005","unstructured":"Massa O, Iafusco D, D'Amato E, et al.. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat. 2005, 25:22-7. 10.1002\/humu.20124","journal-title":"Hum Mutat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae095","article-title":"The changing landscape of neonatal diabetes mellitus in Italy between 2003 and 2022","volume":"109","author":"Rapini N","year":"2024","unstructured":"Rapini N, Delvecchio M, Mucciolo M, et al.. The changing landscape of neonatal diabetes mellitus in Italy between 2003 and 2022. J Clin Endocrinol Metab. 2024, 109:2349-57. 10.1210\/clinem\/dgae095","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S002","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association","year":"2025","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes: standards of care in diabetes-2025. Diabetes Care. 2025, 48:S27-49. 10.2337\/dc25-S002","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0036","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"46","author":"Sacks DB","year":"2023","unstructured":"Sacks DB, Arnold M, Bakris GL, et al.. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2023, 46:e151-99. 10.2337\/dci23-0036","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60098-8","article-title":"The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study","volume":"386","author":"De Franco E","year":"2015","unstructured":"De Franco E, Flanagan SE, Houghton JA, et al.. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015, 386:957-63. 10.1016\/S0140-6736(15)60098-8","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson ER","year":"2006","unstructured":"Pearson ER, Flechtner I, Nj\u00f8lstad PR, et al.. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006, 355:467-77. 10.1056\/NEJMoa061759","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.12.010","article-title":"Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation","volume":"108","author":"Pe\u00f1a-Almazan S","year":"2015","unstructured":"Pe\u00f1a-Almazan S. Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation. Diabetes Res Clin Pract. 2015, 108:e18-20. 10.1016\/j.diabres.2014.12.010","journal-title":"Diabetes Res Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13376","article-title":"Sulfonylurea for improving neurological features in neonatal diabetes: a systematic review and meta-analyses","volume":"23","author":"de Gouveia Buff Passone C","year":"2022","unstructured":"de Gouveia Buff Passone C, Giani E, Vaivre-Douret L, et al.. Sulfonylurea for improving neurological features in neonatal diabetes: a systematic review and meta-analyses. Pediatr Diabetes. 2022, 23:675-92. 10.1111\/pedi.13376","journal-title":"Pediatr Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30106-8","article-title":"Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study","volume":"6","author":"Bowman P","year":"2018","unstructured":"Bowman P, Sulen \u00c5, Barbetti F, et al.. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Lancet Diabetes Endocrinol. 2018, 6:637-46. 10.1016\/S2213-8587(18)30106-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.02.003","article-title":"Neonatal diabetes and the KATP channel: from mutation to therapy","volume":"28","author":"Ashcroft FM","year":"2017","unstructured":"Ashcroft FM, Puljung MC, Vedovato N. Neonatal diabetes and the KATP channel: from mutation to therapy. Trends Endocrinol Metab. 2017, 28:377-87. 10.1016\/j.tem.2017.02.003","journal-title":"Trends Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2494","article-title":"Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons","volume":"99","author":"Carmody D","year":"2014","unstructured":"Carmody D, Bell CD, Hwang JL, et al.. Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. J Clin Endocrinol Metab. 2014, 99:E2709-14. 10.1210\/jc.2014-2494","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1143736","article-title":"Case report: better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants","volume":"14","author":"Mancioppi V","year":"2023","unstructured":"Mancioppi V, Pozzi E, Zanetta S, et al.. Case report: better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants. Front Endocrinol (Lausanne). 2023, 14:1143736. 10.3389\/fendo.2023.1143736","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13575","article-title":"Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control","volume":"35","author":"Stanik J","year":"2018","unstructured":"Stanik J, Dankovcikova A, Barak L, et al.. Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control. Diabet Med. 2018, 35:386-91. 10.1111\/dme.13575","journal-title":"Diabet Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.6.1042","article-title":"DEND syndrome with heterozygous KCNJ11 mutation successfully treated with sulfonylurea","volume":"32","author":"Cho JH","year":"2017","unstructured":"Cho JH, Kang E, Lee BH, Kim GH, Choi JH, Yoo HW. DEND syndrome with heterozygous KCNJ11 mutation successfully treated with sulfonylurea. J Korean Med Sci. 2017, 32:1042-5. 10.3346\/jkms.2017.32.6.1042","journal-title":"J Korean Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000521858","article-title":"Sulfonylurea-insensitive permanent neonatal diabetes caused by a severe gain-of-function Tyr330His substitution in Kir6.2","volume":"95","author":"McClenaghan C","year":"2022","unstructured":"McClenaghan C, Rapini N, De Rose DU, et al.. Sulfonylurea-insensitive permanent neonatal diabetes caused by a severe gain-of-function Tyr330His substitution in Kir6.2. Horm Res Paediatr. 2022, 95:215-23. 10.1159\/000521858","journal-title":"Horm Res Paediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/287912-an-interesting-case-of-sulphonylurea-responsive-permanent-neonatal-diabetes-mellitus-with-potassium-channel-mutation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:33:00Z","timestamp":1777584780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/287912-an-interesting-case-of-sulphonylurea-responsive-permanent-neonatal-diabetes-mellitus-with-potassium-channel-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.108049","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}